TLIS - Talis Biomedical GAAP EPS of -$8.27 misses by $0.02 revenue of $0.58M beats by $0.47M August, 10 2023 05:46 PM Talis Biomedical Corporation 2023-08-10 17:46:25 ET Talis Biomedical press release ( NASDAQ: TLIS ): Q2 GAAP EPS of -$8.27 misses by $0.02 . Revenue of $0.58M (+1.8% Y/Y) beats by $0.47M . For further details see: Talis Biomedical GAAP EPS of -$8.27 misses by $0.02, revenue of $0.58M beats by $0.47M